Medication Abortion in Canada
A Right-to-Health Perspective
Bibliographic Data
| ID | 11038876 |
|---|---|
| Authors | Joanna N Erdman (0000-0003-3578-8523, At the time of the study, the authors were with the Health Equity and Law Clinic, Faculty of Law, University of Toronto, Ontario.), Amy Grenon (At the time of the study, the authors were with the Health Equity and Law Clinic, Faculty of Law, University of Toronto, Ontario.), Leigh Harrison-Wilson (At the time of the study, the authors were with the Health Equity and Law Clinic, Faculty of Law, University of Toronto, Ontario.) |
| Year | 2008 |
| Volume | 98 |
| Issue | 10 |
| Pages | 1764-1769 |
| Publication date | 2008-10-01 |
| Open Access | No |
| Type | ARTICLE |
| Venue | American Journal of Public Health (JOURNAL) |
| Journal identifiers | ISSN: 0090-0036 • E-ISSN: 1541-0048 |
| Publisher | American Public Health Association (PUBLISHER • US) |
| DOI | 10.2105/ajph.2008.134684 |
| PMID | 18703434 |
| PMCID | PMC2636450 |
| OpenAlex | W2111687701 |
| Language | EN |
| Citations received | 4 |
| References cited | 9 |
The right to health under the International Covenant on Economic, Social, and Cultural Rights, to which Canada is a signatory, entitles women to available, accessible, and acceptable abortion care. Abortion care in Canada currently fails this standard. Medication abortion (the use of drugs to terminate a pregnancy) could improve abortion care in Canada, but its potential remains unrealized. This is in part attributable to the unavailability of mifepristone, the safest and most effective pharmaceutical for medication abortion. Given that it could improve abortion care, we investigated why mifepristone remains unapproved in Canada, whether its unavailability is attributable to government inaction, and whether Canada is therefore failing to fulfill its obligations under the right to health
Abortion · Covenant · Family medicine · Government (linguistics) · Health care · Mifepristone · Misoprostol · Political science · Pregnancy · Unavailability · International Human Rights and Reproductive Law · Law · Medicine · Reproductive Health and Contraception · Reproductive Health and Technologies
| Citations per year | 0.24 |
|---|---|
| Citation span | 2009 - 2025 (17) |
| Highly cited | No |